Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-20

FDA Approved: ICOSAPENT ETHYL — Original Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved ICOSAPENT ETHYL from Qilu Pharmaceutical Co., Ltd. via an original application (ANDA218899).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ICOSAPENT ETHYL (icosapent ethyl)

Snippet

ORIG AP for ICOSAPENT ETHYL (ICOSAPENT ETHYL)